2-(2-(2-(2-acetylhydrazinyl)-2-oxoacetamido)propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide;2-?[[1-?[4-?[[[(4-?Fluorophenyl)?methyl]?amino]?carbonyl]?-?1,?6-?dihydro-?5-?hydroxy-?1-?methyl-?6-?oxo-?2-?pyrimidinyl]?-?1-?methylethyl]?amino]?-?2-?oxo-?Acetic Acid 2-?Acetylhydrazide;2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-(2-Acetylhydrazinyl)-2-oxoacetamide) Raltegravir
Raltegravir EP Impurity C is a fully characterized chemical compound used as a reference standard of API Raltegravir. The standard offered is compliant with regulatory guidelines. Raltegravir EP Impurity C is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1391918-17-4
